People · Operator
Named in public records as an officer, director or promoter · active 2014–2024 · Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Optiscan Biomedical Corp | — | Other Health Care | Series B | $131.6M | $443.1M | 2019 |
| Hansen Medical Inc | — | Other Health Care | Series B | $126.0M | $775.4M | 2014 |
| Myoscience, Inc | — | Other | Series B | $122.6M | $83.1M | 2016 |
| PhotoniCare, Inc. | — | Other Health Care | Series A | $19.9M | $19.4M | 2023 |
Cary . Vance at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Cary . Vance on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Ferrari | 1 | 15 |
| Robert Grant | 1 | 12 |
| Dale . Grogan | 1 | 7 |
| Anthony Lando | 1 | 6 |
| Brian Farley | 1 | 5 |
| Richard M. Ferrari | 1 | 5 |
| Paul Mieyal | 1 | 5 |
| Charles Liamos | 1 | 4 |
| Gary Durack | 1 | 4 |
| Aditya Puri | 1 | 4 |
| Clint Carnell | 1 | 4 |
| Jon Serbousek | 1 | 3 |
| Thomas Weldon | 1 | 3 |
| Julie Eskay-Eagle | 1 | 3 |
| Thomas E. Hancock | 1 | 3 |
| KENNETH ABRAMOWITZ | 1 | 3 |
| RUSSELL C. HIRSCH | 1 | 3 |
| Jan Pensaert | 1 | 3 |
| Peter Rule | 1 | 3 |
| Steve . Meyer | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.